Combining language therapy with robot-assisted arm treatment for stroke survivors
Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
['FUNDING_R21'] · NEW YORK UNIVERSITY · NIH-10640826
This study is exploring a new way to help stroke survivors who have trouble with speaking and moving their arms by combining computer-based language therapy with robot-assisted arm exercises, making recovery easier and more effective for them.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10640826 on ClinicalTrials.gov |
What this research studies
This research investigates a new approach to help stroke survivors who experience both language and motor impairments. By integrating computerized aphasia therapy with robot-assisted arm treatment, the study aims to enhance recovery in both areas simultaneously. Patients will participate in combined therapy sessions that target their language deficits while also improving their arm function. This innovative method seeks to make rehabilitation more efficient and potentially reduce costs for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are chronic stroke survivors who experience both language difficulties, such as aphasia, and motor impairments.
Not a fit: Patients who do not have both language and motor deficits may not benefit from this combined treatment approach.
Why it matters
Potential benefit: If successful, this research could significantly improve recovery outcomes for stroke survivors with combined language and motor impairments.
How similar studies have performed: While the integration of language and motor therapies is a novel approach, previous studies have shown promise in treating these domains separately, indicating potential for success in this combined method.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BUCHWALD, ADAM — NEW YORK UNIVERSITY
- Study coordinator: BUCHWALD, ADAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.